Pivotal bioVenture Partners Investment Advisor LLC — 13F Holdings & Portfolio

CIK 1844645 · latest 13F-HR filed 2026-11-13

Pivotal bioVenture Partners Investment Advisor LLC manages $251.8M in 13F-reported U.S. long-equity assets across 14 reported positions as of its 2026-09-30 13F-HR filing. Its largest disclosed positions are PCVX (32.22%), ARQT (10.58%), TRVI (9.91%). Quarter over quarter (versus its 2026-06-30 filing) the fund opened 2 new positions and exited 1; 1 existing position rose in reported value and 9 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$251.8M

Long-equity book

Holdings
14

Distinct positions

Period
2026-09-30

Filed 2026-11-13

Q/Q Activity
+2 / −1 / ↑1 / ↓9

vs 2026-06-30

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q3 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q2 26 → Q3 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

5 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 91.1%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Jun 25, 2026.

Address
501 SECOND STREET
SUITE 200
SAN FRANCISCO, CA 94107
Phone
(415) 697-1002
Name Title / Status Ownership Type
BISGAARD, PETER, TUXEN ControlMANAGING DIRECTOR
since Jun 2022
Less than 5%Individual
HOPFNER, ROBERT, LORNE ControlMANAGING DIRECTOR
since Dec 2017
Less than 5%Individual
PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD ControlGENERAL PARTNER OF PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.
since Dec 2016
75% or moreForeign Entity
PIVOTAL PARTNERS LTD ControlOWNER OF PIVOTAL BIOVENTURE PARTNERS FUND II G.P. LTD
since Dec 2016
75% or moreForeign Entity
PIVOTAL PARTNERS LTD ControlMEMBER
since Oct 2025
75% or moreForeign Entity
TRAVERS, MICHAEL, LAWRENCE ControlUS CHIEF OPERATING OFFICER AND GENERAL COUNSEL
since Aug 2022
Less than 5%Individual
TSE, BRIAN, KIN KWOKOFFICER
since Mar 2018
Less than 5%Individual
CHEN'S GROUP HOLDINGS LIMITED Control
Indirect owner via NAN FUNG INTERNATIONAL HOLDINGS LIMITED
SHAREHOLDER
since Aug 2014
75% or moreForeign Entity
CHEN'S GROUP INTERNATIONAL LIMITED Control
Indirect owner via CHEN'S GROUP HOLDINGS LIMITED
SHAREHOLDER
since Aug 2011
75% or moreForeign Entity
NAN FUNG GROUP HOLDINGS LIMITED Control
Indirect owner via NF INVESTMENT HOLDINGS LIMITED
SHAREHOLDER
since Sep 1999
75% or moreForeign Entity
NAN FUNG INTERNATIONAL HOLDINGS LIMITED Control
Indirect owner via NAN FUNG GROUP HOLDINGS LIMITED
SHAREHOLDER
since Aug 2011
75% or moreForeign Entity
NAN FUNG LIFE SCIENCES HOLDINGS LIMITED Control
Indirect owner via PIVOTAL LIFE SCIENCES HOLDINGS LIMITED
SHAREHOLDER
since Mar 2016
75% or moreForeign Entity
NF INVESTMENT HOLDINGS LIMITED Control
Indirect owner via NAN FUNG LIFE SCIENCES HOLDINGS LIMITED
SHAREHOLDER
since Nov 2012
75% or moreForeign Entity
PIVOTAL LIFE SCIENCES HOLDINGS LIMITED Control
Indirect owner via PIVOTAL PARTNERS LTD
SHAREHOLDER
since Nov 2016
75% or moreForeign Entity
PIVOTAL PARTNERS LTD Control
Indirect owner via PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD
SHAREHOLDER
since Dec 2016
75% or moreForeign Entity
Ownership & leadership changes · 8 filings with changes since Mar 16, 2017

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Jun 25, 2026 filing
  • No longer listedNAN FUNG SCIENCES HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via PIVOTAL LIFE SCIENCES HOLDINGS LIMITED · control person · listed since Mar 2016
  • No longer listedNF INVESTMENT HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG SCIENCES HOLDINGS LIMITED · control person · listed since Nov 2012
  • No longer listedPIVOTAL BIOVENTURE PARTNERS MANAGEMENT LTD · MEMBER · 75% or more · control person · listed since Dec 2016
  • No longer listedPIVOTAL PARTNERS LTD · SHAREHOLDER · 75% or more · indirect via PIVOTAL BIOVENTURE PARTNERS MANAGEMENT LTD · control person · listed since Dec 2016
  • AddedNAN FUNG LIFE SCIENCES HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via PIVOTAL LIFE SCIENCES HOLDINGS LIMITED · control person
  • AddedNF INVESTMENT HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG LIFE SCIENCES HOLDINGS LIMITED · control person
  • ChangedHOPFNER, ROBERT, LORNE · title OFFICER → MANAGING DIRECTOR
  • ChangedPIVOTAL PARTNERS LTD · title OWNER OF PIVOTAL BIOVENTURE PARTNERS FUND II G.P., LTD. → MEMBER / OWNER OF PIVOTAL BIOVENTURE PARTNERS FUND II G.P. LTD
  • ChangedTRAVERS, MICHAEL, LAWRENCE · title CORPORATE COUNSEL AND CHIEF OPERATING OFFICER → US CHIEF OPERATING OFFICER AND GENERAL COUNSEL
May 30, 2024 filing
  • ChangedPIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD · title GENERAL PARTNER OF PIVOTAL BIOVENTURE PARTNERS FUND I, G.P., L.P. → GENERAL PARTNER OF PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.
  • ChangedPIVOTAL PARTNERS LTD · title OWNER OF PIVOTAL BIOVENTURE PARTNERS FUND II, G.P., LTD. → OWNER OF PIVOTAL BIOVENTURE PARTNERS FUND II G.P., LTD.
Jun 23, 2023 filing
  • AddedPIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD · GENERAL PARTNER OF PIVOTAL BIOVENTURE PARTNERS FUND I, G.P., L.P. · 75% or more · control person
  • AddedPIVOTAL PARTNERS LTD · SHAREHOLDER · 75% or more · indirect via PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD · control person
  • AddedPIVOTAL PARTNERS LTD · OWNER OF PIVOTAL BIOVENTURE PARTNERS FUND II, G.P., LTD. · 75% or more · control person
  • AddedTRAVERS, MICHAEL, LAWRENCE · CORPORATE COUNSEL AND CHIEF OPERATING OFFICER · Less than 5% · control person
Jun 28, 2022 filing
  • No longer listedPreston, Heather · OFFICER · Less than 5% · control person · listed since Jul 2018
  • AddedBISGAARD, PETER, TUXEN · MANAGING DIRECTOR · Less than 5% · control person
Jun 14, 2021 filing
  • No longer listedNAN FUNG LIFE SCIENCES LIMITED · SHAREHOLDER · 75% or more · indirect via PIVOTAL PARTNERS LTD. · control person · listed since Nov 2016
  • No longer listedNF INVESTMENT HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via WISDOM SKY INVESTMENTS LIMITED · control person · listed since Nov 2012
  • No longer listedWISDOM SKY INVESTMENTS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG LIFE SCIENCES LIMITED · control person · listed since Mar 2016
  • AddedNAN FUNG SCIENCES HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via PIVOTAL LIFE SCIENCES HOLDINGS LIMITED · control person
  • AddedNF INVESTMENT HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG SCIENCES HOLDINGS LIMITED · control person
  • AddedPIVOTAL LIFE SCIENCES HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via PIVOTAL PARTNERS LTD · control person
Jun 26, 2020 filing
  • AddedCHEN'S GROUP HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG INTERNATIONAL HOLDINGS LIMITED · control person
  • AddedCHEN'S GROUP INTERNATIONAL LIMITED · SHAREHOLDER · 75% or more · indirect via CHEN'S GROUP HOLDINGS LIMITED · control person
  • AddedNAN FUNG GROUP HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via NF INVESTMENT HOLDINGS LIMITED · control person
  • AddedNAN FUNG INTERNATIONAL HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG GROUP HOLDINGS LIMITED · control person
  • AddedNAN FUNG LIFE SCIENCES LIMITED · SHAREHOLDER · 75% or more · indirect via PIVOTAL PARTNERS LTD. · control person
  • AddedNF INVESTMENT HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via WISDOM SKY INVESTMENTS LIMITED · control person
  • AddedWISDOM SKY INVESTMENTS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG LIFE SCIENCES LIMITED · control person
  • ChangedPIVOTAL PARTNERS LTD · indirect via PIVOTAL BIOVENTURE PARTNERS MANAGEMENT LTD: now a control person
Jun 24, 2019 filing
  • AddedPreston, Heather · OFFICER · Less than 5% · control person
  • AddedTSE, BRIAN, KIN KWOK · OFFICER · Less than 5%
Jun 29, 2018 filing
  • No longer listedSaxton, Tracy, M · OFFICER · Less than 5% · control person · listed since Dec 2016
  • AddedHOPFNER, ROBERT, LORNE · OFFICER · Less than 5% · control person
Mar 16, 2017 filing (earliest on record)
  • ListedPIVOTAL BIOVENTURE PARTNERS MANAGEMENT LTD · MEMBER · 75% or more · control person
  • ListedPIVOTAL PARTNERS LTD · SHAREHOLDER · 75% or more · indirect via PIVOTAL BIOVENTURE PARTNERS MANAGEMENT LTD
  • ListedSaxton, Tracy, M · OFFICER · Less than 5% · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Top Adds (vs prior quarter)

Show all 1 →

Top Trims

Show all 9 →

Pivotal bioVenture Partners Investment Advisor LLC Holdings (2026-09-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 VAXCYTE INC PCVX 92243G108 $81.1M 32.22% 1,425,470 SH
2 ARCUTIS BIOTHERAPEUTICS INC ARQT 03969K108 $26.6M 10.58% 1,008,174 SH
3 TREVI THERAPEUTICS INC TRVI 89532M101 $25.0M 9.91% 1,742,672 SH
4 AVALYN PHARMACEUTICALS INC AVLN 05348Y105 $24.7M 9.81% 866,792 SH
5 EVOMMUNE INC EVMN 30054Y107 $15.9M 6.32% 1,926,943 SH
6 IMMUNOME INC IMNM 45257U108 $15.8M 6.26% 732,512 SH
7 OCULIS HOLDING AG OCS H5870P102 $15.5M 6.15% 1,658,907 SH
8 OBSIDIAN THERAPEUTICS INC OBX 67448A106 $11.8M 4.69% 860,343 SH
9 AVALO THERAPEUTICS INC AVTX 05338F306 $6.7M 2.64% 434,033 SH
10 BRAVEHEART BIO INC BRVE 10567X101 $6.4M 2.55% 317,351 SH
11 ZENAS BIOPHARMA INC ZBIO 98937L105 $6.3M 2.50% 233,176 SH
12 MAPLIGHT THERAPEUTICS INC MPLT 56565P103 $6.2M 2.47% 611,446 SH
13 RALLYBIO CORP RLYB 75120L209 $5.2M 2.05% 300,579 SH
14 BIOAGE LABS INC BIOA 09077V100 $4.6M 1.84% 653,374 SH
Filing History
Period Filed AUM Holdings Accession
2026-09-30 2026-11-13 $251.8M 14 0001012975-26-001045
2026-06-30 2026-08-13 $307.8M 13 0001012975-26-000759
2026-03-31 2026-05-14 $279.8M 13 0001012975-26-000421
2025-12-31 2026-02-13 $258.7M 12 0001012975-26-000133
2025-09-30 2025-11-13 $173.0M 10 0001012975-25-000748
Filer Information
Address
501 2ND ST, SUITE 200
SAN FRANCISCO, CA 94107
Phone
(415) 948-7474
Filing Manager
Pivotal bioVenture Partners Investment Advisor LLC
SAN FRANCISCO, CA
Signatory
Robert Hopfner
Managing Partner